[1]艾婷婷?刘思捷?蔡珍.体外膜肺氧合在急性心肌梗死合并心源性休克患者中的应用研究进展[J].心血管病学进展,2024,(1):65.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.017]
 AI Tingting,LIU Sijie,CAI Zhen.Application of ECMO in Patients with AMI Complicated with Cardiogenic Shock[J].Advances in Cardiovascular Diseases,2024,(1):65.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.017]
点击复制

体外膜肺氧合在急性心肌梗死合并心源性休克患者中的应用研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年1期
页码:
65
栏目:
综述
出版日期:
2024-02-21

文章信息/Info

Title:
Application of ECMO in Patients with AMI Complicated with Cardiogenic Shock
作者:
艾婷婷?刘思捷?蔡珍
(四川大学华西医院心脏内科,四川 成都 610041)
Author(s):
AI TingtingLIU SijieCAI Zhen
(Department of Cardiology,West China Hospital,Sichuan University,Chengdu 610041,Sichuan,China)
关键词:
体外膜肺氧合急性心肌梗死心源性休克呼吸循环支持
Keywords:
Extracorporeal membrane oxygenationAcute myocardial infarctionCardiogenic shockRespiratory circulation support
DOI:
10.16806/j.cnki.issn.1004-3934.2024.01.017
摘要:
心源性休克(CS)是急性心肌梗死(AMI)常见的并发症,也是AMI患者死亡率增高的重要原因。体外膜肺氧合(ECMO)能提供持续、有效的呼吸循环支持,可稳定患者血流动力学,减轻组织低灌注造成的全身器官功能损害,为AMI合并CS患者心功能恢复赢得时间,在AMI合并CS治疗中凸显出重要价值。不过ECMO技术复杂,临床管理难度较大,现就ECMO在AMI合并CS患者中的应用研究进展进行综述,为临床AMI合并CS治疗及ECMO技术开展提供相关参考。
Abstract:
Cardiogenic shock(CS) is a common complication of acute myocardial infarction(AMI) and an important cause of increased mortality in patients with AMI. Extracorporeal membrane oxygenation(ECMO) can provide continuous and effective respiratory circulation support,stabilize hemodynamics of patients,reduce systemic organ function damage caused by tissue hypoperfusion,and gain time for cardiac function recovery in patients with AMI complicated with CS. ECMO highlights its important value in the treatment of AMI with CS. However,ECMO technology is complex and the clinical management is difficult. This paper reviews the research progress on application of ECMO in patients with AMI complicated with CS,so as to provide relevant reference for the clinical treatment of AMI with CS and the development of ECMO technology.基金项目:四川省卫生健康委员会科研课题( 20PJ045)通信作者:艾婷婷,E-mail:Ai_TTing1355@163.com

参考文献/References:

[1] 申立波,付美娇,陈璟,等. 急性心肌梗死合并心源性休克的临床特点和住院死亡影响因素分析[J]. 宁夏医科大学学报,2022,44(9):913-917.
[2] Thiele H,Ohman EM,e Waha-Thiele S,et al. Management of cardiogenic shock complicating myocardial infarction:an update 2019[J]. Eur Heart J,2019,40(32):2671-2683.
[3] Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC) Developed with the special contribution of the Heart Failure Association(HFA) of the ESC[J]. Eur Heart J,2016,37(27):2129-2200.
[4] 屠国伟,罗哲,王春生,等. 复旦大学附属中山医院心源性休克VA-ECMO治疗规范(v1.2019)[J]. 中国临床医学,2019,26(4):667-672.
[5] Baran DA,Grines CL,Bailey S,et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock:this document was endorsed by the American College of Cardiology(ACC),the American Heart Association(AHA),the Society of Critical Care Medicine(SCCM),and the Society of Thoracic Surgeons(STS) in April 2019[J]. Catheter Cardiovasc Interv,2019,94(1):29-37.
[6] 韩宗茂,高洁,高传玉,等. 早期血运重建及体外膜肺氧合支持治疗急性心肌梗死合并心原性休克的疗效观察及影响因素分析[J]. 中国循环杂志,2021,36(5):433-438.
[7] Scholz KH,Maier SKG,Maier LS,et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction(STEMI) patients presenting with and without haemodynamic instability:results from the German prospective,multicentre FITT-STEMI trial[J]. Eur Heart J,2018,39(13):1065-1074.
[8] 卢峰. 急诊PCI对老年急性心肌梗死合并心源性休克患者的疗效评价[J]. 中西医结合心血管病电子杂志,2021,9(15):34-36.
[9] Writing Committee Members,Lawton JS,Tamis-Holland JE,et al. 2021 ACC/AHA/SCAI Guideline for coronary artery revascularization:a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J]. J Am Coll Cardiol,2022,79(2):e21-e129.
[10] 郭超,杨昊翰,王心宇,等. 主动脉内球囊反搏置入时机对急性心肌梗死合并心原性休克患者预后的影响[J]. 中国循环杂志,2022,37(8):782-788.
[11] Grandin EW,Nunez JI,Willar B,et al. Mechanical left ventricular unloading in patients undergoing venoarterial extracorporeal membrane oxygenation[J]. J Am Coll Cardiol,2022,79(13):1239-1250.
[12] 国家心血管病医疗质量控制中心专家委员会体外循环与体外生命支持专家工作组,吉冰洋. 2021年中国体外生命支持医疗质量控制报告[J]. 中国循环杂志,2022,37(12):1195-1201.
[13] 廖付军,鲍海龙,韦波,等. VA-ECMO联合IABP在急性心肌梗死PCI术后并发难治性心源性休克中的应用[J]. 临床心血管病杂志,2021,37(11):992-997.
[14] 张华忠,武澎,陈旭锋等. 体外膜肺氧合治疗急性心肌梗死合并心源性休克的临床研究[J].中华急诊医学杂志,2021,30(9):1058-1063.
[15] Fried JA,Griffin JM,Masoumi A,et al. Predictors of survival and ventricular recovery following acute myocardial infarction requiring extracorporeal membrane oxygenation therapy[J]. ASAIO J,2022,68(6):800-807.
[16] 解衍博,侯剑峰,刘盛,等. 静脉-动脉模式体外膜肺氧合机械辅助在心脏外科手术围术期的应用[J]. 中国循环杂志,2021,36(4):360-366.
[17] 杨超,彭桂林,杨汉宇,等. 肺移植术中体外膜肺氧合插管方式及应用策略[J]. 中华移植杂志电子版,2020,14(5):290-293.
[18] Keller SP. Management of peripheral venoarterial extracorporeal membrane oxygenation in cardiogenic shock[J]. Crit Care Med,2019,47(9):1235-1242.
[19] Iner H,Gokalp O,Besir Y,et al. Afterload increase in veno-arterial extracorporeal membrane oxygenation[J]. Artif Organs,2018,42(1):106.
[20] Pineton de Chambrun M,Bréchot N,Combes A. Venoarterial extracorporeal membrane oxygenation in cardiogenic shock:indications,mode of operation,and current evidence[J]. Curr Opin Crit Care,2019,25(4):397-402.
[21] McGugan PL. The role of venoarterial extracorporeal membrane oxygenation in postcardiotomy cardiogenic shock[J]. Crit Care Nurs Clin North Am,2019,31(3):419-436.
[22] 赵举,崔勇丽,刘刚. ECMO中的抗凝管理[J]. 中国急救医学,2021,41(7):607-609.
[23] Guimbretière G,Anselmi A,Roisne A,et al. Prognostic impact of blood product transfusion in VA and VV ECMO[J]. Perfusion,2019,34(3):246-253.
[24] Esper SA,Wallisch WJ 4th,Ryan J,et al. Platelet transfusion is associated with 90-day and 1-year mortality for adult patients requiring veno-arterial extracorporeal membrane oxygenation[J]. Vox Sang,2021,116(4):440-450.
[25] Thomas J,Kostousov V,Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation[J]. Semin Thromb Hemost,2018,44(1):20-29.
[26] 张海涛,高润霖,胡盛寿,等. 中国心脏重症镇静镇痛专家共识[J]. 中华医学杂志,2017,97(10):726-734.
[27] Chow SY,Hwang NC. Update on anesthesia management for explantation of veno-arterial extracorporeal membrane oxygenation in adult patients[J]. Ann Card Anaesth,2019,22(4):422-429.
[28] 闵苏,黄宇光,米卫东,等. 不同情况下成人体外膜肺氧合临床应用专家共识(2020版)[J].中国循环杂志,2020,35(11):1052-1063.
[29] Lüsebrink E,Stremmel C,Stark K,et al. Update on weaning from veno-arterial extracorporeal membrane oxygenation[J]. J Clin Med,2020,9(4):992.
[30] Wagner JF,Abfalterer H,?zpeker C,et al. Benefit of extracorporeal membrane oxygenation in myocardial infarction-induced cardiogenic shock[J]. J Cardiovasc Surg(Torino),2023,64(2):207-214.
[31] 芮子傲,戴东普,郭影影,等. 主动脉内球囊反搏联合体外膜肺氧合对于急性心肌梗死合并心源性休克患者的疗效及相关影响因素分析[J]. 中国全科医学,2022,25(21):2597-2604.
[32] 许智晶,孙荣青,刘瑞芳. 静脉-动脉体外膜肺氧合与主动脉内球囊反搏对心源性休克患者血流动力学的影响[J]. 中国中西医结合急救杂志,2021,28(1):55-59.
[33] Ouweneel DM,Schotborgh JV,Limpens J,et al. Extracorporeal life support during cardiac arrest and cardiogenic shock:a systematic review and meta-analysis[J]. Intensive Care Med,2016,42(12):1922-1934.
[34] Ahmad S,Ahsan MJ,Ikram S,et al. Impella versus extracorporeal membranous oxygenation (ECMO) for cardiogenic shock:a systematic review and meta-analysis[J]. Curr Probl Cardiol,2023,48(1):101427.
[35] Djordjevic I,Deppe AC,Sabashnikov A,et al. Concomitant ECMO and IABP support in postcardiotomy cardiogenic shock patients[J]. Heart Lung Circ,2021,30(10):1533-1539.
[36] 邱承杰,陈玉善,解金红,等. 体外膜肺氧合联合主动脉内球囊反搏对急性心肌梗死合并心源性休克患者直接经皮冠状动脉介入治疗临床预后的影响[J]. 中国心血管杂志,2021,26(3):257-261.
[37] Murakami T,Sakakura K,Jinnouchi H,et al. Complications related to veno-arterial extracorporeal membrane oxygenation in patients with acute myocardial infarction:VA-ECMO complications in AMI[J]. J Cardiol,2022,79(2):170-178.
[38] 廉波,李勍,陈彧,等. 股动静脉途径插管体外膜式氧合循环辅助的学习曲线[J]. 中国微创外科杂志,2018,18(3):209-212.

相似文献/References:

[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
 LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
 ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(1):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
 YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(1):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
 YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(1):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
 YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(1):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
 WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(1):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
 LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(1):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
 YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(1):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
 CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(1):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
 PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(1):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]

更新日期/Last Update: 2024-03-06